## Abstract Two positron‐emitting analogues of tyrosine, __O__‐[^11^C]methyl‐L‐tyrosine and __O__‐[^18^F]fluoromethyl‐L‐tyrosine were prepared as new tumor imaging agents. The alkylating agent, [^11^C]methyl triflate or [^18^F]fluoromethyl triflate, was simply bubbled through a dimethylsulfoxide so
Radiosynthesis of novel 18F-labelled derivatives of indiplon as potential GABAA receptor imaging tracers for PET
✍ Scribed by Steffen Fischer; Achim Hiller; Matthias Scheunemann; Winnie Deuther-Conrad; Alexander Hoepping; Michael Diekers; Florian Wegner; Peter Brust; Jörg Steinbach
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- French
- Weight
- 246 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The involvement of gamma amino butyric acid (GABA) receptors in a variety of neurological and psychiatric diseases has promoted the development and use of radiolabelled benzodiazepines (BZ) for brain imaging by PET. However, these radioligands are unable to distinguish between the various subtypes of GABA~A~ receptors. Novel non‐BZ such as the pyrazolo‐pyrimidine indiplon proved to be selective for the α~1~‐subunit of the GABA~A~ receptor. Here, we describe the syntheses of four novel ^18^F‐labelled indiplon derivatives. Radiosyntheses were performed via n.c.a. ^18^F‐nucleophilic substitution starting from the tosyl, bromo, and 4‐nitrobenzoyl precursors to obtain fluorine substituted N‐alkylamide side chain derivatives of indiplon, followed by multistep purification using semi‐preparative high‐performance liquid chromatography and solid phase extraction. Tosyl and bromo precursors were converted into ^18^F‐labelled indiplon derivatives with good and reproducible radiochemical yield (RCY) (35–70%, decay corrected), high radiochemical purity (≥98.5%), and high specific activity ( > 150 GBq/µmol). By contrast, a low RCY (5–10%) and specific activity (10–15 GBq/µmol) were achieved for the 4‐nitrobenzoyl precursor. Copyright © 2008 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract In this study, we synthesized and evaluated a new spirocyclic piperidine derivative 3, containing a 4‐fluorobutyl side chain, as a PET radioligand for neuroimaging of σ~1~ receptors. In vitro, compound 3 displayed high affinity for σ~1~ receptors (__K__~i~=1.2 nM) as well as high select
The histamine H3 receptor is implicated in many neurological and psychological disorders and is therefore of interest as a target for pharmacological intervention. The drug development process can be facilitated by using a radiotracer for this receptor in conjunction with single‐photon emission comp
## Abstract Radiolabeled vesamicol analogs are promising candidates as ligands for the vesicular acetylcholine transporter (VAChT) to enable __in vivo__ imaging of early cholinergic degenerations in brain. The 4‐fluorobenzoyl‐substituted azaspirovesamicol derivative FBASV is one out of six novel ve
Inhibitors of tyrosine kinase enzymatic activity represent a promising new class of antineoplastic agents. Although clinical studies performed over the last decade give more insight on the potential therapeutic applications of such drugs, identification of the individual patients who might benefit f